BioStem Technologies, Inc. (BSEM)

OTCMKTS · Delayed Price · Currency is USD
5.21
-0.28 (-5.10%)
At close: Mar 6, 2026
-59.55%
Market Cap 87.58M
Revenue (ttm) 292.21M
Net Income (ttm) 20.20M
Shares Out 16.81M
EPS (ttm) 0.85
PE Ratio 6.10
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 62,637
Average Volume 81,817
Open 5.71
Previous Close 5.49
Day's Range 5.16 - 5.71
52-Week Range 3.09 - 15.74
Beta -0.00
RSI 44.99
Earnings Date Apr 13, 2026

About BioStem Technologies

BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human conne... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 33
Stock Exchange OTCMKTS
Ticker Symbol BSEM
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.